Personalized Medication Software for BCL-2 Inhibitor in AML Patients Using Machine Learning and Genomics
Clinical trial NCT06295029 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06295029
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-01
- Primary completion
- 2027-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.